1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Continuous drug delivery aiming continuous dopaminergic stimulation in Parkinson's disease
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?
(
- Contribution to journal › Scientific review
-
Mark
Factors Contributing to Perceived Walking Difficulties in People with Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Etiology and pathogenesis of parkinson’s disease
2017) p.95-101(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
Oral and infusion levodopa therapy in the management of Parkinson’s disease
2016) p.63-75(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study.
(
- Contribution to journal › Article
- 2011
-
Mark
Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
(
- Contribution to journal › Article
- 2010
-
Mark
The challenge of non-motor symptoms in Parkinson's disease
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Dopamine replacement therapy in Parkinson´s Disease: past, present and future
2009) p.309-334(
- Chapter in Book/Report/Conference proceeding › Book chapter